Salicylate Poisoning: The Mixed Acid–Base Puzzle
Aspirin is the humblest drug in the cabinet — a few pennies a tablet, sold beside the chewing gum. In overdose it becomes one of the most intellectually demanding poisonings in medicine, because it does not attack an organ so much as it hijacks the body's acid–base chemistry. The patient breathes too fast and too deep, their blood turning alkaline at the top and acidic underneath, all at once. Get the chemistry right and you can pull them back with fluid, bicarbonate and a dialysis machine. Miss it — especially the moment the pH tips the wrong way — and a cheap painkiller kills.
A 19-year-old student is brought to the emergency department a few hours after swallowing a large bottle of aspirin. She is restless and sweating, complaining that her ears are ringing and that she can't quite hear the nurse. She is breathing fast and deep — not gasping, but a steady, driven hyperventilation she cannot switch off. Her temperature is creeping up. The first blood gas is baffling: her blood is alkaline, yet the bicarbonate is low and there is a wide anion gap underneath. Two opposite acid–base disturbances are running in the same patient at the same time. The registrar knows the danger is not what the pH is now, but where it is heading — because the moment it starts to fall, the poison begins moving into her brain.
One drug, two poisons
Salicylate is toxic in two directions at once, and that is the whole story. Aspirin (acetylsalicylic acid) is rapidly hydrolysed to salicylate, and it is salicylate that poisons. It does two very different things to the body. First, it directly stimulates the respiratory centre in the brainstem, driving deep, fast breathing that blows off carbon dioxide — a respiratory alkalosis, appearing early and often before the patient looks unwell. Second, and more sinister, it wrecks the mitochondria: it uncouples oxidative phosphorylation and interferes with enzymes of the Krebs (citric acid) cycle. Energy that should have been captured as ATP is released as heat, cells switch to anaerobic metabolism, lactate piles up, and organic acids accumulate — a wide-anion-gap metabolic acidosis. The signature of serious salicylate poisoning, especially in adults, is these two disturbances coexisting: a MIXED respiratory alkalosis and metabolic acidosis.
Why the mitochondria overheat
Uncoupling is worth picturing, because it explains most of the clinical picture. Normally the mitochondrion pumps protons across its inner membrane and lets them flow back only through the ATP-synthase turbine, capturing that energy as ATP — energy in an orderly channel. Salicylate punches leaks in the membrane so the protons pour back uncontrolled, bypassing the turbine. The cell burns fuel furiously but makes little ATP; the wasted energy escapes as heat, which is why these patients run hot — hyperthermia, sweating, and a soaring metabolic rate. Starved of aerobic ATP, tissues turn to anaerobic glycolysis and generate lactate, while the crippled Krebs cycle spills further acids. Add the hyperventilation-driven loss of CO₂ on top, and you have the full mixed disturbance. The heat and the acid come from the same broken engine.
Think of the mitochondrion as a hydroelectric dam. Water (protons) is held behind the wall and released only through the turbines, where its energy is captured as electricity (ATP). Salicylate drills holes in the dam wall. The water still rushes through — faster than ever — but it bypasses the turbines, so almost no electricity is made. All that pent-up energy dissipates as noise and heat and churning foam. The reservoir empties, the lights dim, and the whole valley warms up. That is uncoupling: maximum burn, minimum useful work, and heat pouring out of a system that is running flat-out for nothing.
The toxidrome at the bedside
The clinical picture follows directly from the chemistry. The earliest and most characteristic symptom is tinnitus — ringing in the ears — and, at higher levels, reversible deafness; a patient who overdosed on aspirin and can't hear you well is salicylate poisoning until proven otherwise. Then comes the driven hyperventilation, nausea and vomiting (worsening fluid loss), hyperthermia and profuse sweating, and a restless agitation. Fluid losses are large and often underestimated: vomiting, sweating and the raised metabolic rate together leave these patients profoundly dehydrated. In severe poisoning the two most feared complications are non-cardiogenic pulmonary oedema and cerebral oedema — the brain and lungs leaking fluid — heralded by confusion, seizures and coma. A deteriorating conscious level in salicylate poisoning is an emergency, not a detail.
- Aspirin is hydrolysed to salicylate; the toxicity is metabolic, not organ-specific damage.
- Two hits: direct respiratory-centre stimulation (respiratory alkalosis) + uncoupled mitochondria (metabolic acidosis).
- Uncoupling wastes fuel as heat → hyperthermia; anaerobic shift + crippled Krebs cycle → lactate and a wide anion gap.
- In adults the classic gas is a MIXED respiratory alkalosis + metabolic acidosis at once.
- Early clue = tinnitus/deafness; also hyperventilation, nausea, sweating, hyperthermia, agitation.
- Severe poisoning: pulmonary and cerebral oedema, confusion, seizures, coma — a true emergency.
Why pH is everything
Salicylate is a weak acid, and a weak acid's whereabouts are dictated by pH. This is the single most important idea in the poisoning, and it comes straight from the Principles of Pharmacology chapter on weak-acid ionisation and pH-dependent distribution. As a weak acid, salicylate exists in two forms: ionised (charged, water-loving, trapped in the bloodstream) and un-ionised (neutral, fat-loving, able to slip across cell membranes — including the blood–brain barrier). The balance between them depends on pH. In an acidic environment, more salicylate becomes un-ionised, and that un-ionised fraction crosses into the brain. The central nervous system concentration — not the blood level alone — is what kills. So as the blood pH falls, salicylate moves out of the safe compartment (plasma) and into the dangerous one (brain). Acidaemia is not just a marker of severity; it actively drives the poison toward its target. Every management decision bends around keeping the blood, and especially the urine, alkaline.
This is why intubating a salicylate-poisoned patient can be lethal. That relentless hyperventilation is not the problem — it is compensation, the body's attempt to keep the blood alkaline and the salicylate out of the brain. Sedate and paralyse the patient, and their minute ventilation falls; CO₂ climbs, the pH plummets, and salicylate floods across the blood–brain barrier. Patients have died at the moment of intubation. If a salicylate patient truly needs an airway, you must match or exceed their own huge minute ventilation and never let them hypoventilate — and ideally dialyse them instead. The instinct to "calm the fast breather down" is exactly wrong here.
Management: a pharmacokinetic rescue
There is no receptor antidote. You cannot block salicylate — you can only get it out. Unlike paracetamol with N-acetylcysteine or opioids with naloxone, there is no molecule that reverses salicylate at a receptor. The whole rescue is pharmacokinetic: support the patient and accelerate elimination. Start with resuscitation — generous intravenous fluids to correct the large deficits, and glucose, because the brain can be starved of glucose even when the blood level looks normal (neuroglycopenia), so give dextrose to any patient with altered mental status. Then the first pH tool: urinary alkalinisation with intravenous sodium bicarbonate. The logic is ion trapping, the mirror image of the brain problem. Alkalinise the urine and salicylate in the renal tubule becomes ionised — charged, water-trapped, unable to be reabsorbed — so it is flushed out in the urine. The same weak-acid chemistry that lets acid drive salicylate into the brain lets you use alkali to drive it out through the kidney.
Alkalinisation has one great enemy: potassium. If the patient is hypokalaemic, the kidney reabsorbs potassium by pumping hydrogen ions into the urine instead — producing paradoxically acidic urine no matter how much bicarbonate you give, and defeating the whole strategy. So you cannot alkalinise the urine until you have corrected and are actively replacing potassium. This is the classic trap: bicarbonate running, urine stubbornly acidic, because nobody checked the potassium. The Enhanced-elimination & Antidotes chapter frames urinary alkalinisation as the model example of ion trapping — salicylate is its textbook case — and it belongs beside activated charcoal (useful early, and in staggered doses because aspirin can form slow-dissolving concretions in the stomach).
When the patient is truly sick, chemistry is not enough — you take the poison out by machine. The definitive treatment for severe poisoning is haemodialysis. Salicylate is an almost ideal molecule to dialyse — small, water-soluble, poorly protein-bound at toxic levels — and dialysis does two jobs at once: it strips salicylate from the blood and corrects the acidosis. The EXTRIP workgroup, whose recommendations sit in the Enhanced-elimination & Antidotes chapter, lists salicylate among the poisonings for which dialysis is clearly indicated. Reach for it when the level is very high, when there is a significant metabolic acidosis that resists treatment, altered mental status or seizures, renal failure (the kidney is the escape route — lose it and levels climb), or pulmonary or cerebral oedema. In practice the decision to dialyse turns on how sick the patient is, not on the number alone — a confused, acidotic patient needs the machine even at a level another patient would tolerate.
No antidote — a purely kinetic rescue in three layers. (1) Resuscitate: IV fluids for the large deficit; dextrose for any altered mental status (neuroglycopenia). (2) Trap and excrete: sodium bicarbonate to alkalinise the urine (ion trapping) — but replace potassium first, or the urine will never turn alkaline; activated charcoal early, repeated if levels keep rising. (3) Extract: haemodialysis for the severe end — very high levels, refractory acidosis, altered mental state, seizures, renal failure, or pulmonary/cerebral oedema. Throughout, protect the airway strategy: do not let the patient hypoventilate, because a falling pH sends salicylate into the brain.
- No receptor antidote exists — management is entirely pharmacokinetic: support + enhance elimination.
- Resuscitate first: generous IV fluids and dextrose (neuroglycopenia can exist at a normal blood glucose).
- Urinary alkalinisation with sodium bicarbonate traps ionised salicylate in the tubule and enhances excretion.
- Correct potassium first — hypokalaemia makes the urine acidic and defeats alkalinisation.
- Haemodialysis for severe toxicity: very high levels, refractory acidosis, altered mental state, renal failure, oedema.
- Avoid letting the patient hypoventilate; intubation is dangerous unless ventilation matches their high minute volume.
- Sedating and intubating a hyperventilating patient without matching their minute ventilation — the pH crashes and salicylate floods the brain. People have died at intubation.
- Pouring in bicarbonate while ignoring a low potassium — the urine stays acidic, alkalinisation fails, and the level won't fall.
- Trusting a single "normal" or even alkalotic gas as reassurance. A rising or falling trend and mental status matter more than one number — and a normalising pH in a deteriorating patient can mean the acidosis is winning.
A 22-year-old presents after an aspirin overdose with tinnitus, deep rapid breathing and agitation. The gas shows a respiratory alkalosis with a coexisting raised-anion-gap metabolic acidosis; potassium is 3.0 mmol/L. Which step is essential before urinary alkalinisation with sodium bicarbonate can work?
- Salicylate poisons in two directions: it stimulates the respiratory centre (respiratory alkalosis) and uncouples oxidative phosphorylation while blocking the Krebs cycle (heat, lactate, wide-anion-gap metabolic acidosis) — the classic MIXED picture in adults.
- Clinically: tinnitus/deafness, driven hyperventilation, nausea, sweating, hyperthermia, agitation; severe cases bring pulmonary and cerebral oedema, seizures and coma.
- pH is everything: as blood pH falls, more salicylate becomes un-ionised and crosses into the brain — so acidosis is dangerous and you must not let the patient hypoventilate (beware sedation/intubation).
- No receptor antidote — a pharmacokinetic rescue: fluids and glucose, urinary alkalinisation with bicarbonate (replace potassium first), and haemodialysis for severe toxicity.
- Goldfrank's Toxicologic Emergencies — Salicylates.
- Rang & Dale's Pharmacology — Anti-inflammatory drugs / aspirin and salicylate toxicity.
- Katzung Basic & Clinical Pharmacology — NSAIDs; management of the poisoned patient.
- British National Formulary (BNF) — Emergency treatment of poisoning: salicylates.
- Juurlink DN, et al. Extracorporeal Treatment for Salicylate Poisoning: EXTRIP workgroup systematic review and recommendations.
- Chapman BJ, Proudfoot AT. Adverse events of urinary alkalinisation and haemodialysis in salicylate poisoning; UpToDate/TOXBASE salicylate (aspirin) poisoning topic.
